Cure My Disease

Don't miss your cure!

 Log in / Sign up

A new approach aims to help autistic kids master everyday movements

NCT ID NCT07797439

Symptom relief Sponsor: Groupe Hospitalier Nord-Essonne Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 01, 2026 · Last updated Sep 02, 2026 · Updated 1 time

Summary

This study tests whether Neuromotor Task Training (NTT) can help autistic children aged 6 to 10 improve a specific motor skill they find difficult in daily life, such as catching a ball or putting on a coat. Each child works with a therapist to practice a chosen skill, with the task, environment, and feedback adjusted to support learning. The study uses a single-case design, measuring each child's progress repeatedly before, during, and after training to see if improvements occur and are maintained.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Neuromotor Task Training, a task-oriented rehabilitation approach that practices meaningful functional motor skills with adapted task constraints, environment, and feedback.
What this could lead to
If effective, this approach could offer a practical, personalized way to help autistic children improve motor skills that matter in daily life, potentially informing broader rehabilitation strategies.
What could go wrong
This is a small, early-stage study with only 12 participants, so results may not apply broadly. The training's success depends on individual factors, and the study does not compare against a control group, making it harder to confirm cause and effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 12 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 10 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children aged 6 to 10 years. * Diagnosis of autism spectrum disorder. * Presence of motor difficulties documented by clinical assessment and/or standardized motor assessment. * Ability to understand and participate in the proposed motor training sessions. * Written informed consent from the child's legal representative(s). * Child assent whenever possible, according to age and level of understanding. * Participation in the usual care pathway at the investigating center. Exclusion Criteria: * Intelligence quotient below 70, when documented, or severe cognitive impairment preventing understanding of the tasks or participation in the training sessions. * Medical, neurological, orthopedic, or sensory condition that would contraindicate participation in motor training. * Uncontrolled epilepsy or any unstable medical condition that could interfere with participation. * Severe behavioral difficulties making repeated assessment or motor training impossible. * Ongoing participation in another interventional study that could interfere with the outcomes of this study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Autism spectrum disorder (ASD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autism spectrum disorder developmental coordination disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Autism spectrum disorder (ASD)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Groupe Hospitalier Nord-Essonne

    Bures-sur-Yvette, Essones, 91440, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.